METHOD FOR OBTAINING PURE ENANTIOMERS OF A PYRIDAZINONE DERIVATIVE

The invention provides a novel, crystalline polymorphic form of (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile and a method for making the polymorph. The compound is useful as a cardiotonic agent.

Saved in:
Bibliographic Details
Main Authors MUTTONEN, ESA, BAECKSTROEM, REIJO, TANNINEN, VELI PEKKA, HYPPOELAE, RIIKKA, KAUKONEN, JUKKA, LEHTONEN, JORMA, TIMMERBACKA, MIKA
Format Patent
LanguageEnglish
Published 29.08.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a novel, crystalline polymorphic form of (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile and a method for making the polymorph. The compound is useful as a cardiotonic agent.
Bibliography:Application Number: HUP9904150